| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 288 | 529 | 33 | 12 | 129 | 138 | 153 | 159 | 151 | 170 | 191 | 240 | |
Growth YoY Revenue Growth YoY% | -8.1 | 73.7 | -89.3 | -95.9 | -55.2 | -73.8 | 360.4 | 1,226.4 | 17.1 | 22.8 | 25.4 | 51.6 |
| 236 | 437 | 43 | 24 | 135 | 147 | 149 | 151 | 147 | 149 | 158 | 195 | |
| 52 | 91 | -10 | -12 | -7 | -9 | 4 | 7 | 4 | 21 | 33 | 45 | |
OPM OPM% | 18.0 | 17.3 | -29.4 | -98.6 | -5.2 | -6.7 | 2.4 | 4.7 | 2.8 | 12.1 | 17.5 | 18.9 |
| 7 | 458 | 11 | 13 | 16 | 220 | 15 | 12 | 22 | -3 | 7 | 7 | |
Interest Expense Interest ExpenseCr | 21 | 3 | 0 | 0 | 10 | -27 | 1 | 2 | 1 | -2 | 1 | 1 |
Depreciation DepreciationCr | 14 | 20 | 0 | 0 | 6 | 7 | 7 | 7 | 9 | 8 | 8 | 8 |
PBT PBTCr | 24 | 527 | 1 | 1 | -7 | 230 | 10 | 10 | 16 | 12 | 33 | 43 |
| 5 | 33 | 0 | 0 | -1 | 8 | 2 | 2 | 7 | -3 | 8 | 9 | |
| 20 | 494 | 1 | 0 | -6 | 222 | 9 | 8 | 10 | 15 | 25 | 34 | |
Growth YoY PAT Growth YoY% | -29.3 | 2,071.2 | -94.2 | -98.7 | -128.2 | -55.0 | 756.4 | 1,910.0 | 273.1 | -93.2 | 184.1 | 324.8 |
NPM NPM% | 6.8 | 93.4 | 3.0 | 3.3 | -4.3 | 160.8 | 5.7 | 5.1 | 6.3 | 8.9 | 12.8 | 14.2 |
| 3.3 | 83.5 | 0.2 | 0.1 | -0.8 | 33.0 | 1.3 | 1.0 | 1.2 | 1.8 | 2.8 | 3.9 |
| Quarter | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 288 | 529 | 33 | 12 | 129 | 138 | 153 | 159 | 151 | 170 | 191 | 240 | |
Growth YoY Revenue Growth YoY% | -8.1 | 73.7 | -89.3 | -95.9 | -55.2 | -73.8 | 360.4 | 1,226.4 | 17.1 | 22.8 | 25.4 | 51.6 |
| 236 | 437 | 43 | 24 | 135 | 147 | 149 | 151 | 147 | 149 | 158 | 195 | |
| 52 | 91 | -10 | -12 | -7 | -9 | 4 | 7 | 4 | 21 | 33 | 45 | |
OPM OPM% | 18.0 | 17.3 | -29.4 | -98.6 | -5.2 | -6.7 | 2.4 | 4.7 | 2.8 | 12.1 | 17.5 | 18.9 |
| 7 | 458 | 11 | 13 | 16 | 220 | 15 | 12 | 22 | -3 | 7 | 7 | |
Interest Expense Interest ExpenseCr | 21 | 3 | 0 | 0 | 10 | -27 | 1 | 2 | 1 | -2 | 1 | 1 |
Depreciation DepreciationCr | 14 | 20 | 0 | 0 | 6 | 7 | 7 | 7 | 9 | 8 | 8 | 8 |
PBT PBTCr | 24 | 527 | 1 | 1 | -7 | 230 | 10 | 10 | 16 | 12 | 33 | 43 |
| 5 | 33 | 0 | 0 | -1 | 8 | 2 | 2 | 7 | -3 | 8 | 9 | |
| 20 | 494 | 1 | 0 | -6 | 222 | 9 | 8 | 10 | 15 | 25 | 34 | |
Growth YoY PAT Growth YoY% | -29.3 | 2,071.2 | -94.2 | -98.7 | -128.2 | -55.0 | 756.4 | 1,910.0 | 273.1 | -93.2 | 184.1 | 324.8 |
NPM NPM% | 6.8 | 93.4 | 3.0 | 3.3 | -4.3 | 160.8 | 5.7 | 5.1 | 6.3 | 8.9 | 12.8 | 14.2 |
| 3.3 | 83.5 | 0.2 | 0.1 | -0.8 | 33.0 | 1.3 | 1.0 | 1.2 | 1.8 | 2.8 | 3.9 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 653 | 716 | 765 | 757 | 780 | 891 | 1,039 | 1,207 | 1,281 | 574 | 649 | 753 |
Growth Revenue Growth% | -1.1 | 9.6 | 6.9 | -1.2 | 3.0 | 14.3 | 16.5 | 16.2 | 6.1 | -55.2 | 13.0 | 30.1 |
| 544 | 610 | 631 | 631 | 635 | 709 | 843 | 978 | 1,027 | 581 | 602 | 649 | |
| 109 | 106 | 134 | 126 | 144 | 183 | 196 | 229 | 254 | -7 | 47 | 104 | |
OPM OPM% | 16.7 | 14.8 | 17.6 | 16.7 | 18.5 | 20.5 | 18.8 | 19.0 | 19.9 | -1.2 | 7.2 | 13.8 |
| -1 | 15 | 16 | 120 | 33 | 23 | 44 | 7 | 432 | 292 | 36 | 33 | |
Interest Expense Interest ExpenseCr | 106 | 88 | 28 | 92 | 107 | 100 | 96 | 92 | 51 | 3 | 1 | 0 |
Depreciation DepreciationCr | 85 | 88 | 87 | 104 | 90 | 87 | 131 | 57 | 53 | 24 | 31 | 32 |
PBT PBTCr | -83 | -55 | 36 | 50 | -20 | 18 | 13 | 87 | 582 | 258 | 51 | 104 |
| -24 | -16 | 14 | 21 | 1 | 21 | 15 | 39 | 160 | 7 | 8 | 21 | |
PAT PATCr | -59 | -39 | 22 | 29 | -21 | -3 | -2 | 48 | 421 | 251 | 43 | 83 |
Growth PAT Growth% | 50.8 | 33.3 | 156.2 | 31.7 | -173.2 | 85.2 | 31.7 | 2,325.6 | 781.1 | -40.6 | -82.8 | -64.3 |
NPM NPM% | -9.0 | -5.5 | 2.9 | 3.8 | -2.7 | -0.3 | -0.2 | 4.0 | 32.9 | 43.6 | 6.6 | 11.1 |
| -14.3 | -9.2 | 4.9 | -6.2 | -4.3 | -0.5 | -0.4 | 8.1 | 91.2 | 37.3 | 5.2 | 9.8 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue RevenueCr | 653 | 716 | 765 | 757 | 780 | 891 | 1,039 | 1,207 | 1,281 | 574 | 649 | 753 |
Growth Revenue Growth% | -1.1 | 9.6 | 6.9 | -1.2 | 3.0 | 14.3 | 16.5 | 16.2 | 6.1 | -55.2 | 13.0 | 30.1 |
| 544 | 610 | 631 | 631 | 635 | 709 | 843 | 978 | 1,027 | 581 | 602 | 649 | |
| 109 | 106 | 134 | 126 | 144 | 183 | 196 | 229 | 254 | -7 | 47 | 104 | |
OPM OPM% | 16.7 | 14.8 | 17.6 | 16.7 | 18.5 | 20.5 | 18.8 | 19.0 | 19.9 | -1.2 | 7.2 | 13.8 |
| -1 | 15 | 16 | 120 | 33 | 23 | 44 | 7 | 432 | 292 | 36 | 33 | |
Interest Expense Interest ExpenseCr | 106 | 88 | 28 | 92 | 107 | 100 | 96 | 92 | 51 | 3 | 1 | 0 |
Depreciation DepreciationCr | 85 | 88 | 87 | 104 | 90 | 87 | 131 | 57 | 53 | 24 | 31 | 32 |
PBT PBTCr | -83 | -55 | 36 | 50 | -20 | 18 | 13 | 87 | 582 | 258 | 51 | 104 |
| -24 | -16 | 14 | 21 | 1 | 21 | 15 | 39 | 160 | 7 | 8 | 21 | |
PAT PATCr | -59 | -39 | 22 | 29 | -21 | -3 | -2 | 48 | 421 | 251 | 43 | 83 |
Growth PAT Growth% | 50.8 | 33.3 | 156.2 | 31.7 | -173.2 | 85.2 | 31.7 | 2,325.6 | 781.1 | -40.6 | -82.8 | -64.3 |
NPM NPM% | -9.0 | -5.5 | 2.9 | 3.8 | -2.7 | -0.3 | -0.2 | 4.0 | 32.9 | 43.6 | 6.6 | 11.1 |
| -14.3 | -9.2 | 4.9 | -6.2 | -4.3 | -0.5 | -0.4 | 8.1 | 91.2 | 37.3 | 5.2 | 9.8 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 42 | 45 | 46 | 48 | 60 | 60 | 60 | 60 | 59 | 69 | 87 | 87 |
Reserves ReservesCr | 476 | 486 | 507 | 540 | 581 | 544 | 541 | 622 | 872 | 1,030 | 1,297 | 1,387 |
| 951 | 1,005 | 936 | 356 | 323 | 315 | 334 | 371 | 221 | 221 | 257 | 262 | |
| 746 | 601 | 534 | 980 | 906 | 901 | 865 | 771 | 12 | 45 | 32 | 35 | |
| 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,165 | 1,438 | 1,673 | 1,771 | |
| 926 | 832 | 842 | 836 | 863 | 944 | 1,075 | 1,165 | 661 | 865 | 977 | 1,023 | |
| 1,288 | 1,306 | 1,181 | 1,088 | 1,007 | 874 | 725 | 660 | 504 | 573 | 697 | 748 | |
| 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,165 | 1,438 | 1,673 | 1,771 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 42 | 45 | 46 | 48 | 60 | 60 | 60 | 60 | 59 | 69 | 87 | 87 |
Reserves ReservesCr | 476 | 486 | 507 | 540 | 581 | 544 | 541 | 622 | 872 | 1,030 | 1,297 | 1,387 |
| 951 | 1,005 | 936 | 356 | 323 | 315 | 334 | 371 | 221 | 221 | 257 | 262 | |
| 746 | 601 | 534 | 980 | 906 | 901 | 865 | 771 | 12 | 45 | 32 | 35 | |
| 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,165 | 1,438 | 1,673 | 1,771 | |
| 926 | 832 | 842 | 836 | 863 | 944 | 1,075 | 1,165 | 661 | 865 | 977 | 1,023 | |
| 1,288 | 1,306 | 1,181 | 1,088 | 1,007 | 874 | 725 | 660 | 504 | 573 | 697 | 748 | |
| 2,215 | 2,138 | 2,023 | 1,924 | 1,870 | 1,818 | 1,801 | 1,824 | 1,165 | 1,438 | 1,673 | 1,771 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | 96 | 73 | -64 | 125 | 135 | 150 | 195 | -163 | -29 | -68 | |
| -30 | -31 | -17 | -12 | -9 | -10 | 5 | -13 | -104 | -113 | -73 | |
| -48 | -69 | -62 | 100 | -133 | -124 | -141 | -186 | 699 | 72 | 142 | |
Net Cash Flow Net Cash FlowCr | 2 | -4 | -6 | 23 | -17 | 1 | 14 | -4 | 431 | -69 | 1 |
Free Cash Flow Free Cash FlowCr | 49 | 75 | 53 | -79 | 115 | 131 | 137 | 182 | -205 | -55 | -155 |
CFO To PAT CFO To PAT% | -135.3 | -244.2 | 332.6 | -222.5 | -591.1 | -4,287.9 | -6,992.4 | 406.9 | -38.7 | -11.4 | -158.4 |
CFO To EBITDA CFO To EBITDA% | 72.9 | 90.2 | 54.4 | -51.1 | 86.7 | 73.8 | 76.8 | 84.9 | -64.2 | 418.1 | -145.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 79 | 96 | 73 | -64 | 125 | 135 | 150 | 195 | -163 | -29 | -68 | |
| -30 | -31 | -17 | -12 | -9 | -10 | 5 | -13 | -104 | -113 | -73 | |
| -48 | -69 | -62 | 100 | -133 | -124 | -141 | -186 | 699 | 72 | 142 | |
Net Cash Flow Net Cash FlowCr | 2 | -4 | -6 | 23 | -17 | 1 | 14 | -4 | 431 | -69 | 1 |
Free Cash Flow Free Cash FlowCr | 49 | 75 | 53 | -79 | 115 | 131 | 137 | 182 | -205 | -55 | -155 |
CFO To PAT CFO To PAT% | -135.3 | -244.2 | 332.6 | -222.5 | -591.1 | -4,287.9 | -6,992.4 | 406.9 | -38.7 | -11.4 | -158.4 |
CFO To EBITDA CFO To EBITDA% | 72.9 | 90.2 | 54.4 | -51.1 | 86.7 | 73.8 | 76.8 | 84.9 | -64.2 | 418.1 | -145.6 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 187 | 148 | 259 | 187 | 128 | 426 | 392 | 326 | 581 | 509 | 1,141 | 2,757 |
Price To Earnings Price To Earnings | 12.0 | 6.5 | 6.9 | 1.4 | 2.3 | 26.5 | 32.5 | |||||
Price To Sales Price To Sales | 0.3 | 0.2 | 0.3 | 0.3 | 0.2 | 0.5 | 0.4 | 0.3 | 0.5 | 0.9 | 1.8 | 3.7 |
Price To Book Price To Book | 0.8 | 0.6 | 0.9 | 0.5 | 0.3 | 1.1 | 1.0 | 0.7 | 0.6 | 0.5 | 0.8 | 1.9 |
EV To EBITDA EV To EBITDA | 13.0 | 10.7 | 8.1 | 10.3 | 7.8 | 7.6 | 6.8 | 5.1 | 0.7 | -17.0 | 15.6 | 23.5 |
GPM GPM% | 38.3 | 34.2 | 39.9 | 37.9 | 41.1 | 41.7 | 39.0 | 36.0 | 40.2 | 41.1 | 46.6 | 46.6 |
OPM OPM% | 16.7 | 14.8 | 17.6 | 16.7 | 18.5 | 20.5 | 18.8 | 19.0 | 19.9 | -1.2 | 7.2 | 13.8 |
NPM NPM% | -9.0 | -5.5 | 2.9 | 3.8 | -2.7 | -0.3 | -0.2 | 4.0 | 32.9 | 43.6 | 6.6 | 11.1 |
ROCE ROCE% | 1.3 | 2.2 | 4.6 | 8.2 | 5.3 | 7.5 | 7.0 | 11.6 | 66.8 | 23.0 | 3.7 | 7.0 |
ROE ROE% | -11.3 | -7.4 | 4.0 | 4.9 | -3.3 | -0.5 | -0.4 | 7.0 | 45.3 | 22.8 | 3.1 | 5.7 |
ROA ROA% | -2.6 | -1.8 | 1.1 | 1.5 | -1.1 | -0.2 | -0.1 | 2.6 | 36.2 | 17.4 | 2.6 | 4.7 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 187 | 148 | 259 | 187 | 128 | 426 | 392 | 326 | 581 | 509 | 1,141 | 2,757 |
Price To Earnings Price To Earnings | 12.0 | 6.5 | 6.9 | 1.4 | 2.3 | 26.5 | 32.5 | |||||
Price To Sales Price To Sales | 0.3 | 0.2 | 0.3 | 0.3 | 0.2 | 0.5 | 0.4 | 0.3 | 0.5 | 0.9 | 1.8 | 3.7 |
Price To Book Price To Book | 0.8 | 0.6 | 0.9 | 0.5 | 0.3 | 1.1 | 1.0 | 0.7 | 0.6 | 0.5 | 0.8 | 1.9 |
EV To EBITDA EV To EBITDA | 13.0 | 10.7 | 8.1 | 10.3 | 7.8 | 7.6 | 6.8 | 5.1 | 0.7 | -17.0 | 15.6 | 23.5 |
GPM GPM% | 38.3 | 34.2 | 39.9 | 37.9 | 41.1 | 41.7 | 39.0 | 36.0 | 40.2 | 41.1 | 46.6 | 46.6 |
OPM OPM% | 16.7 | 14.8 | 17.6 | 16.7 | 18.5 | 20.5 | 18.8 | 19.0 | 19.9 | -1.2 | 7.2 | 13.8 |
NPM NPM% | -9.0 | -5.5 | 2.9 | 3.8 | -2.7 | -0.3 | -0.2 | 4.0 | 32.9 | 43.6 | 6.6 | 11.1 |
ROCE ROCE% | 1.3 | 2.2 | 4.6 | 8.2 | 5.3 | 7.5 | 7.0 | 11.6 | 66.8 | 23.0 | 3.7 | 7.0 |
ROE ROE% | -11.3 | -7.4 | 4.0 | 4.9 | -3.3 | -0.5 | -0.4 | 7.0 | 45.3 | 22.8 | 3.1 | 5.7 |
ROA ROA% | -2.6 | -1.8 | 1.1 | 1.5 | -1.1 | -0.2 | -0.1 | 2.6 | 36.2 | 17.4 | 2.6 | 4.7 |
| Market CapitalizationMkt CapCr | 4,202 | 4,194 | 2,901 | 2,757 | 2,175 | 2,143 | 1,841 |
| Close PriceClose₹ | 2,540.90 | 418.25 | 1,693.90 | 317.05 | 492.30 | 232.15 | 1,655.40 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 37.91 | 52.41 | 51.49 | 32.48 | 82.46 | 67.68 | 33.99 |
| Price To SalesPS | 5.50 | 4.06 | 3.34 | 3.66 | 3.26 | 1.12 | 4.14 |
| RevenueRevenueCr | 764 | 1,032 | 870 | 753 | 668 | 1,909 | 444 |
| Revenue Growth TTMRev Gr TTM% | 14.7% | 18.2% | 30.1% | 10.6% | 15.2% | ||
| PAT Growth TTMPAT Gr TTM% | -48.5% | 40.7% | -64.3% | 127.6% | 27.3% |
| Market CapitalizationMkt CapCr | 4,202 | 4,194 | 2,901 | 2,757 | 2,175 | 2,143 | 1,841 |
| Close PriceClose₹ | 2,540.90 | 418.25 | 1,693.90 | 317.05 | 492.30 | 232.15 | 1,655.40 |
| IndustryIndustry | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations | Pharma Formulations |
| Price To EarningsPE | 37.91 | 52.41 | 51.49 | 32.48 | 82.46 | 67.68 | 33.99 |
| Price To SalesPS | 5.50 | 4.06 | 3.34 | 3.66 | 3.26 | 1.12 | 4.14 |
| RevenueRevenueCr | 764 | 1,032 | 870 | 753 | 668 | 1,909 | 444 |
| Revenue Growth TTMRev Gr TTM% | 14.7% | 18.2% | 30.1% | 10.6% | 15.2% | ||
| PAT Growth TTMPAT Gr TTM% | -48.5% | 40.7% | -64.3% | 127.6% | 27.3% |